The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 09, 2014
Filed:
Sep. 25, 2009
Jan Heeres, Vosselaar, BE;
Paulus Joannes Lewi, Turnhout, BE;
Marc René DE Jonge, Tilburg, NL;
Lucien Maria Henricus Koymans, Retie, BE;
Frederik Frans Desiré Daeyaert, Beerse, BE;
Hendrik Maarten Vinkers, Antwerp, BE;
Jéròme Emile Georges Guillemont, Ande, FR;
Elisabeth Therese Jeanne Pasquier, Le Neubourg, FR;
Frank Xavier Jozef Herwig Arts, Brasschaat, BE;
Jan Heeres, Vosselaar, BE;
Paulus Joannes Lewi, Turnhout, BE;
Paul Adriaan Jan Janssen, Vosselaar, BE;
Marc René de Jonge, Tilburg, NL;
Lucien Maria Henricus Koymans, Retie, BE;
Frederik Frans Desiré Daeyaert, Beerse, BE;
Hendrik Maarten Vinkers, Antwerp, BE;
Jéròme Emile Georges Guillemont, Ande, FR;
Elisabeth Therese Jeanne Pasquier, Le Neubourg, FR;
Janssen Pharmaceutica N.V., Beerse, BE;
Abstract
This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a=a-a=a- and -b=b-b=b- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; Ris hydrogen; aryl; formyl; Calkylcarbonyl; Calkyl; Calkyloxycarbonyl; substituted Calkyl, Calkylcarbonyl, Calkyloxycarbonyl, Calkylcarbonyloxy; substituted CalkyloxyCalkylcarbonyl; Ris hydroxy, halo, optionally substituted Calkyl, Ccycloalkyl, optionally substituted Calkenyl, optionally substituted Calkynyl, Calkyloxy, Calkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(Calkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, —S(═O)R, —NH—S(═O)R, —C(═O)R, —NHC(═O)H, —C(═O)NHNH, —NHC(═O)R, —C(═NH)Ror a 5-membered heterocycle; Xis —NR—, —NH—NH—, —N═N—, —O—, —C(═O)—, Calkanediyl, —CHOH—, —S—, —S(═O)—, —X—Calkanediyl- or —Calkanediyl-X—; Ris NHR; NRR; —C(═O)—NHR; —C(═O)—NRR; —C(═O)—R; —CH═N—NH—C(═O)—R; substituted Calkyl; optionally substituted CalkyloxyCalkyl; substituted Calkenyl; substituted Calkynyl; Calkyl substituted with hydroxy and a second substituent; —C(═N—O—R)—Calkyl; R; or —X—R; Ris halo, hydroxy, Calkyl, Ccycloalkyl, Calkyloxy, cyano, nitro, polyhaloCalkyl, polyhaloCalkyloxy, aminocarbonyl, Calkyloxycarbonyl, Calkylcarbonyl, formyl, amino, mono- or di(Calkyl)amino; and pharmaceutical compositions comprising them.